P4‐316: Stabilization of neurotoxic Alzheimer amyloid‐beta oligomers by protein engineering

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Alzheimer's & Dementia

• Publication date

  2011-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jalz.2011.09.061
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparing the folding free‐energy landscapes of Aβ42 variants with different aggregation properties

  2010cited by this paper
• Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering

  2010cited by this paper
• Structure–activity relationship of amyloid fibrils

  2009cited by this paper
• Amyloid β-Protein Assembly and Alzheimer Disease*

  2009cited by this paper
• An Analytical Solution to the Kinetics of Breakable Filament Assembly

  2009cited by this paper
• Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.

  2009cited by this paper
• Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.

  2009cited by this paper
• Structural characterization of a soluble amyloid beta-peptide oligomer.

  2009cited by this paper
• Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.

  2008cited by this paper
• Why Alzheimer’s is a disease of memory: The attack on synapses by Aß oligomers (ADDLs)

  2008cited by this paper
• Recombinant amyloid beta-peptide production by coexpression with an affibody ligand

  2008cited by this paper
• Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation

  2008cited by this paper
• Abeta-globulomers are formed independently of the fibril pathway.

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Sensitive ELISA detection of amyloid‐β protofibrils in biological samples

  2007cited by this paper
• Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides

  2007cited by this paper
• Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils

  2007cited by this paper
• The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study.

  2007cited by this paper
• Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine*

  2007cited by this paper
• Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

  2006cited by this paper
• Protein misfolding, functional amyloid, and human disease.

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42

  2006cited by this paper
• On the nucleation of amyloid β‐protein monomer folding

  2005cited by this paper
• Structure of the cross-β spine of amyloid-like fibrils

  2005cited by this paper
• Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease

  2005cited by this paper
• Multiple Assembly Pathways Underlie Amyloid-β Fibril Polymorphisms

  2005cited by this paper
• Solution NMR Studies of the Aβ(1−40) and Aβ(1−42) Peptides Establish that the Met35 Oxidation State Affects the Mechanism of Amyloid Formation

  2004cited by this paper
• Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

  2001cited by this paper
• Structural studies of soluble oligomers of the alzheimer β-amyloid peptide

  2000cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper

• Active Immunization Targeting Amyloid β for the Treatment of Alzheimer’s Disease

  2025cites this paper
• Distinct Flower signaling domains orchestrate cellular fitness via secreted vesicles in Aβ-induced neurodegeneration

  2025cites this paper
• Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion

  2024cites this paper
• Diversity of Aβ aggregates produced in a gut-based Drosophila model of Alzheimer’s disease

  2024cites this paper
• Probing differences among Aβ oligomers with two triangular trimers derived from Aβ

  2023cites this paper
• Lipids uniquely alter the secondary structure and toxicity of amyloid beta 1–42 aggregates

  2023cites this paper
• Recent advances in Alzheimer’s disease pathogenesis and therapeutics from an immune perspective

  2023cites this paper
• Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update

  2023cites this paper
• Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future

  2023cites this paper
• The Small Molecule GAL-201 Efficiently Detoxifies Soluble Amyloid β Oligomers: New Approach towards Oral Disease-Modifying Treatment of Alzheimer’s Disease

  2022cites this paper
• Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

  2022influential citation
• Relationship between Cognitive Dysfunction and Age-Related Variability in Oxidative Markers in Isolated Mitochondria of Alzheimer’s Disease Transgenic Mouse Brains

  2022influential citation
• Glucosamine and Its Analogues as Modulators of Amyloid-β Toxicity.

  2021cites this paper
• Sleep deprivation regulates availability of PrPC and Aβ peptides which can impair interaction between PrPC and laminin and neuronal plasticity

  2020cites this paper
• Ultrastructural evidence for self-replication of Alzheimer-associated Aβ42 amyloid along the sides of fibrils

  2020cites this paper
• A Novel Aβ40 Assembly at Physiological Concentration

  2020cites this paper
• The interaction of insoluble Amyloid‐β with soluble Amyloid‐β dimers decreases Amyloid‐β plaque numbers

  2020cites this paper
• Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers

  2020cites this paper
• Out-of-register parallel β-sheets and antiparallel β-sheets coexist in 150 kDa oligomers formed by Amyloid-β(1-42).

  2020cites this paper
• Out-of-register parallel β-sheets and antiparallel β-sheets coexist in 150 kDa oligomers formed by Aβ(1-42)

  2020cites this paper
• Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue

  2020cites this paper
• Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain.

  2019cites this paper
• Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes

  2019cites this paper
• Mercury and Alzheimer’s Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization

  2019cites this paper
• Rationale for the development of an Alzheimer’s disease vaccine

  2019cites this paper
• Discovery of conformation-sensitive anti-amyloid protofibril monoclonal antibodies using an engineered chaperone-like amyloid-binding protein

  2019cites this paper
• Controlling the Oligomerization State of Aβ-Derived Peptides with Light.

  2018cites this paper
• Looking at the Disordered Proteins through the Computational Microscope

  2018cites this paper
• An Efficient Method for the Expression and Purification of Aβ(M1-42).

  2018cites this paper
• Why Abeta42 Is Much More Toxic Than Abeta40.

  2018cites this paper
• Protofibrillar and Fibrillar Amyloid-β Binding Proteins in Cerebrospinal Fluid

  2018cites this paper
• Advancements of the sFIDA method for oligomer‐based diagnostics of neurodegenerative diseases

  2018cites this paper
• Side-chain moieties from the N-terminal region of Aβ are Involved in an oligomer-stabilizing network of interactions

  2018cites this paper
• NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer’s disease: an investigation by docking, molecular dynamics, and DFT studies

  2018influential citation
• A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers

  2018cites this paper
• α‐Mangostin decreases β‐amyloid peptides production via modulation of amyloidogenic pathway

  2017cites this paper
• Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.

  2017cites this paper
• Conformational Ensembles of the Wild-Type and S8C Aβ1-42 Dimers.

  2017cites this paper
• Insights into protein misfolding and aggregation enabled by solid-state NMR spectroscopy.

  2017cites this paper
• How accurate are your simulations? Effects of confined aqueous volume and AMBER FF99SB and CHARMM22/CMAP force field parameters on structural ensembles of intrinsically disordered proteins: Amyloid-β42 in water

  2017cites this paper
• High-Resolution Structures of the Amyloid-β 1-42 Dimers from the Comparison of Four Atomistic Force Fields.

  2017cites this paper
• Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS)

  2017cites this paper
• Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology

  2017cites this paper
• Monomeric Aβ1–40 and Aβ1–42 Peptides in Solution Adopt Very Similar Ramachandran Map Distributions That Closely Resemble Random Coil

  2016cites this paper
• Fibrils of Truncated Pyroglutamyl-Modified Aβ Peptide Exhibit a Similar Structure as Wildtype Mature Aβ Fibrils

  2016cites this paper
• Nicotinic Acetylcholine Receptor Technologies

  2016cites this paper
• An Environmentally Sensitive Fluorescent Dye as a Multidimensional Probe of Amyloid Formation

  2016cites this paper
• Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics

  2016influential citation
• β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor

  2016cites this paper
• TMAO-Protein Preferential Interaction Profile Determines TMAO's Conditional In Vivo Compatibility.

  2016cites this paper
• Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products

  2016cites this paper
• Polymorphism of fibrillar structures depending on the size of assembled Aβ17-42 peptides

  2016cites this paper
• Natural Modulators of Amyloid formation in Alzheimer's disease

  2016cites this paper
• Caractérisation du rôle de l’amyline (IAPP) dans le diabète de type 2 : études de dérivés peptidiques et de composés inhibiteurs de la formation d’amyloïde

  2016cites this paper
• The elusive nature and diagnostics of misfolded Aβ oligomers

  2015cites this paper
• Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors

  2015cites this paper
• Modulation of Alzheimer's amyloid β peptide self-assembly : Insights into molecular mechanisms of peptide aggregation associated with Alzheimer's disease

  2015cites this paper
• Amyloid-β Protofibrils in Alzheimer´s Disease : Focus on Antibodies, Inflammation and Astrocytes

  2015cites this paper
• Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds

  2015cites this paper
• Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes

  2015cites this paper
• Antiparallel β-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-β Peptides When They Form 150-kDa Oligomers.

  2015cites this paper
• Curcumin Binding to Beta Amyloid: A Computational Study

  2015cites this paper
• Non-chaperone Proteins Can Inhibit Aggregation and Cytotoxicity of Alzheimer Amyloid β Peptide

  2014influential citation
• β-Hairpin-Mediated Formation of Structurally Distinct Multimers of Neurotoxic Prion Peptides

  2014cites this paper
• Intracellular selection of peptide inhibitors that target disulphide‐bridged Aβ42 oligomers

  2014cites this paper
• Simultaneous Changes of Spatial Memory and Spine Density after Intrahippocampal Administration of Fibrillar Aβ 1–42 to the Rat Brain

  2014cites this paper
• Protein disulfide engineering

  2014cites this paper
• Thermodynamically stable amyloid-β monomers have much lower membrane affinity than the small oligomers

  2013cites this paper
• The role of amyloid β in the pathogenesis of Alzheimer's disease

  2013cites this paper
• Structural Insights into Aβ42 Oligomers Using Site-directed Spin Labeling*♦

  2013cites this paper
• Structural Studies of Cystatin B Amyloid Fibre and Oligomer

  2013cites this paper
• ATR-FTIR: a "rejuvenated" tool to investigate amyloid proteins.

  2013cites this paper
• Identification of fibril-like tertiary contacts in soluble monomeric α-synuclein.

  2013cites this paper
• Disulfide bonds in amyloidogenesis diseases related proteins

  2013cites this paper
• Molecular structures of amyloid and prion fibrils: consensus versus controversy.

  2013cites this paper
• Thermodynamic Description of Beta Amyloid Formation

  2013cites this paper
• The role of amyloidogenic protein oligomerization in neurodegenerative disease

  2013cites this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cites this paper
• Modulation of beta-amyloid aggregation by engineering the sequence connecting beta-strand forming domains.

  2012cites this paper
• Coping with young onset dementia: perspectives of couples and professionals

  2012cites this paper
• Alzheimer's disease and the amyloid β-protein.

  2012cites this paper
• Large Aggregates Are the Major Soluble Aβ Species in AD Brain Fractionated with Density Gradient Ultracentrifugation

  2012cites this paper
• Toxic fibrillar oligomers of amyloid-β have cross-β structure

  2012influential citation
• Driving forces and structural determinants of steric zipper peptide oligomer formation elucidated by atomistic simulations.

  2012cites this paper
• Towards a Pharmacophore for Amyloid

  2011cites this paper
• Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β Peptides*

  2011cites this paper
• Human Apolipoprotein A-I-Derived Amyloid: Its Association with Atherosclerosis

  2011cites this paper
• The structure of monomeric components of self-assembling CXCR4 antagonists determines the architecture of resulting nanostructures

  2011cites this paper
• Probing amyloid fibril growth by two-dimensional near-ultraviolet spectroscopy.

  2011cites this paper
• Recent progress in understanding Alzheimer's β-amyloid structures.

  2011cites this paper
• Molecular engineering of a secreted, highly homogeneous, and neurotoxic aβ dimer.

  2011cites this paper
• Alzheimer's disease: β‐amyloid plaque formation in human brain

  2011cites this paper
• Mapping the Conformational Dynamics and Pathways of Spontaneous Steric Zipper Peptide Oligomerization

  2011cites this paper
• BRICHOS-a Novel Anti-Amyloid Chaperone Studies on Pro-Surfactant Protein C

  2011cites this paper
• A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain‐derived synaptic plasticity‐disrupting Aβ

  2011cites this paper
• BRICHOS domain associated with lung fibrosis, dementia and cancer – a chaperone that prevents amyloid fibril formation?

  2011cites this paper